BiotechTube
Home/Advance Pharmaceutical/Sarah Jennings, MBA
SJ

Sarah Jennings, MBA

Chief Financial Officer

Advance Pharmaceutical

Therapeutic Areas

OncologyRare Diseases

Advance Pharmaceutical Pipeline

DrugIndicationPhase
AP-101Non-Small Cell Lung Cancer (NSCLC) with specific mutationsPhase 2
AP-202Advanced Solid TumorsPhase 1/2
AP-301Genetic Disorder AlphaPhase 1/2
AP-401Oncology (undisclosed target)Preclinical
AP-501Rare Metabolic DiseasePreclinical

Leadership Team at Advance Pharmaceutical

DR
Dr. Robert Chen, M.D., Ph.D.
Chief Executive Officer
DA
Dr. Aris Kekis, Ph.D.
Chief Scientific Officer
DL
Dr. Lisa Monroe, M.D.
Chief Medical Officer
DP
David Park, J.D.
Chief Business Officer
MR
Michael Rodriguez
Vice President, Operations
DE
Dr. Elena Petrova, Ph.D.
Vice President, Research
JK
James Kim
Vice President, Clinical Development
AW
Amanda White
Vice President, Regulatory Affairs
JW
Janet Williams
Chairperson of the Board
DT
Dr. Thomas Wright, Ph.D.
Independent Director
View full Advance Pharmaceutical profile